https://h89inhibitor.com/analy....tical-efficiency-inv
This in silico ZIKV vaccine was formulated using a consensus sequence, generated from ZIKV sequences found within the database. Based on predictive models for binding to human leukocyte antigen (HLA) class II and class I molecules, alongside their promiscuity and immunogenicity, we singled out CD4+ and CD8+ T-cell epitopes across all ZIKV proteins. The ZIKV envelop
Like
Comment
Share
